Parametric Portfolio Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
ESCM
BTW
VVP
Parametric Portfolio Associates's MEDP Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Medpace (MEDP) stake by 3.5% in Q1 2022, selling an estimated $457K and leaving 76,618 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1226.
Parametric Portfolio Associates first reported a position in MEDP in Q3 2016 and has held it in 22 quarters since. The position peaked at $17.3M in Q4 2021. 348 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.
- Parametric Portfolio Associates held 76,618 shares of Medpace worth $12.5M as of Q1 2022.
- Parametric Portfolio Associates sold 2,769 Medpace shares in Q1 2022, an estimated $457K.
- Medpace made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1226 holding.
- Parametric Portfolio Associates first reported a position in Medpace in Q3 2016 and has held it in 22 quarters since.
- Parametric Portfolio Associates's Medpace position peaked at $17.3M in Q4 2021.
- 348 funds tracked by Wall St. Rank held Medpace as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.